Conversations in Drug Development
από Boyds
Τελευταίο επεισόδιο
Ada Lovelace Day: Breaking Barriers, Shaping Futures
Ada Lovelace Day: Breaking Barriers, Shaping Futures
Σχετικά με αυτό το podcast
Welcome to Conversations in Drug Development, brought to you by the team at Boyds. This podcast is for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development.
Επεισόδια
Τα νεότερα 20 από 28 επεισόδια
- Ada Lovelace Day: Breaking Barriers, Shaping Futures · 18 λεπ. · Επεισόδιο 30To celebrate Ada Lovelace Day, women from Boyds share their career journeys, the challenges they’ve overcome and their advice for the next generation of women in science.
- EU Pharma Reform 2026: What Every Developer Needs to Know · 38 λεπ. · Επεισόδιο 29In this episode, Katherine Bowen and Shalini Gupta discuss the EU pharmaceutical legislation reform — a comprehensive update to regulations and directives that will affect drug…
- Live Biotherapeutics: Navigating the Next Frontier in Drug Development · 32 λεπ. · Επεισόδιο 28In this episode, Boyds' experts explore the emerging field of live biotherapeutic products (LBPs), explaining what they are, how they differ from everyday probiotics, and their…
- UK Clinical Trial Regulation: What Sponsors Need to Know About UK CTR 2025 · 26 λεπ. · Επεισόδιο 27In this episode, experts at Boyds, Chris Moore and Shalini Gupta break down the UK Clinical Trial Regulation (UK CTR), exploring why the reform was introduced and highlighting…
- How Will the EU Biotech Act Transform Biotechnology Regulation in Europe? · 30 λεπ. · Επεισόδιο 25In this episode of Conversations in Drug Development, host Harriet Edwards and regulatory experts Kelsey Lennox and Emma Eamon McGowan discuss the EU Biotech Act, a major…
- Navigating the FDA Landscape: More Changes, and What's Next? · 27 λεπ. · Επεισόδιο 24In this episode, Eric Hardter and guest Kelsey Lenoch discuss recent US FDA developments, including leadership changes at CBER and CDER, staffing impacts on orphan product…
- At the forefront of innovation: Prof Alan Boyd reflects on the last 20 years in drug development · 40 λεπ. · Επεισόδιο 23In this special episode of Conversations in Drug Development, host Harriet Edwards sits down with Professor Alan Boyd, founder and CEO of Boyds, to reflect on the company’s…
- Navigating the New FDA Landscape: Opportunities and Challenges Ahead · 36 λεπ. · Επεισόδιο 21In the latest episode of Conversations in Drug Development, Dr Katherine Bowen and Dr Eric Hardter discuss the ever-changing US regulatory landscape under the new administration…
- From Lab to Launch – Avoiding the Pitfalls of Drug Development · 28 λεπ. · Επεισόδιο 20In this episode, Dr Neil Fish and Dr Ami Patel dive into the real-world challenges of drug development - from early-stage planning to regulatory hurdles and everything in between.
- Crystal Ball Gazing: What Does the Future Hold for Regulatory Affairs in Drug Development for 2025 · 33 λεπ. · Επεισόδιο 19In this episode, Harriet Edwards from Boyds hosts a discussion on 2025 predictions in drug development and regulatory affairs. Joined by regulatory experts Dr. Katherine Bowen…
- How to Effectively De-Risk your IND Process · 53 λεπ. · Επεισόδιο 18In this episode, Dr. Nick Meyers and Dr. Eric Hardter, discuss effective strategies for de-risking Investigational New Drug (IND) applications. Discover key insights on how to…
- Understanding EU Medical Device Regulations: Key Insights for Developers and Innovators · 24 λεπ. · Επεισόδιο 17In this episode, host Harriet Edwards is joined by Eamonn McGowran, an expert in medical device regulations, to explore the complex and rapidly evolving regulatory landscape for…
- Patients as Partners: Advocacy's Role in Shaping Drug Development · 27 λεπ. · Επεισόδιο 16In this episode, host Harriet Edwards and Senior Clinical Project Manager, Chris Moore, discuss the vital role of patient and public involvement in drug development, particularly…
- Navigating the Future of EU Health Technology Assessments · 29 λεπ. · Επεισόδιο 15In this episode, host Dr Julie Warner is joined by experts from Decisive Consulting, Esther Nzenza, and Kevin Asher to discuss the upcoming joint clinical assessment (JCA)…
- A Guide to Marketing Authorization Applications in Europe · 28 λεπ. · Επεισόδιο 14In this episode, host Harriet Edwards is joined by Dr Katherine Bowen to explore the regulatory fundamentals for obtaining marketing authorisation in Europe, focusing on the…
- Navigating the new EU Clinical Trials Regulation · 28 λεπ. · Επεισόδιο 12In this episode, host Harriet Edwards is joined by Dr Katherine Bowen and Shalini Gupta to explore the transformative changes in the European Union’s clinical trial landscape…
- Advances in Cell-Based Immunotherapies: CAR-T Cell Therapy vs TCR Therapy · 28 λεπ. · Επεισόδιο 13In this episode of Conversations in Drug Development, host Harriet Edwards is joined by two regulatory experts from Boyds, Dr Patrick Ginty and Monica Pianella, to discuss…
- Demystifying Regulatory Designations in Drug Development · 26 λεπ. · Επεισόδιο 11In this episode, Dr Katherine Bowen and Dr Julie Warner delve into the world of regulatory designations, providing clarity on what these designations offer, the products that…
- Exploring Genome Editing Technologies in Drug Development · 24 λεπ. · Επεισόδιο 10In this episode, host Dr. Katherine Bowen, is joined by Harriet Edwards, Associate Director in Regulatory Affairs, to explore the fascinating world of genome editing…
- The Most Essential Tips for Biotechs Seeking Investment · 23 λεπ. · Επεισόδιο 9Dr Nick Myers and Dr Neil Fish, share their extensive experience and insights into navigating the complexities of funding and investment. They delve into what makes an effective…
